RAC 0.59% $1.71 race oncology ltd

Industry news, page-1832

  1. 1,102 Posts.
    lightbulb Created with Sketch. 11815
    Drug induced cardiotoxicity market in 2023 was $1.3B USD, while anti-cancer market is near $150B USD. Where is the value for cardioprotection?

    The value is in the anti-cancer efficacy, which is why compounds like dexrazoxane really aren't worth anything. It's anti-cancer effects first and foremost, then cardioprotection thereafter.

    Anti-cancer drugs with novel mechanisms of action drive multi-billion dollar buyouts, not cardioprotective agents. All you need to do is show me a multi-billion dollar cardioprotection buyout example.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.